Navalign LLC’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.14M Buy
1,784
+41
+2% +$41.9K 0.5% 32
2026
Q1
$1.6M Hold
1,743
0.4% 43
2025
Q4
$1.87M Sell
1,743
-200
-10% -$191K 0.46% 34
2025
Q3
$1.48M Buy
1,943
+23
+1% +$17.1K 0.39% 42
2025
Q2
$1.5M Sell
1,920
-10
-0.5% -$7.77K 0.41% 41
2025
Q1
$1.59M Sell
1,930
-23
-1% -$19.1K 0.45% 36
2024
Q4
$1.51M Sell
1,953
-53
-3% -$43.9K 0.44% 38
2024
Q3
$1.78M Sell
2,006
-6
-0.3% -$5.39K 0.52% 31
2024
Q2
$1.82M Hold
2,012
0.57% 29
2024
Q1
$1.57M Hold
2,012
0.52% 33
2023
Q4
$1.17M Hold
2,012
0.41% 46
2023
Q3
$1.08M Hold
2,012
0.41% 45
2023
Q2
$944K Buy
2,012
+5
+0.2% +$2.1K 0.38% 49
2023
Q1
$689K Sell
2,007
-60
-3% -$20.2K 0.29% 73
2022
Q4
$756K Hold
2,067
0.31% 67
2022
Q3
$668K Hold
2,067
0.3% 66
2022
Q2
$670K Sell
2,067
-27
-1% -$8.11K 0.29% 70
2022
Q1
$597K Buy
2,094
+83
+4% +$21.4K 0.25% 80
2021
Q4
$555K Sell
2,011
-150
-7% -$38K 0.22% 90
2021
Q3
$499K Sell
2,161
-41
-2% -$10.1K 0.21% 93
2021
Q2
$506K Sell
2,202
-1
-0% -$201 0.21% 92
2021
Q1
$412K Buy
+2,203
New +$431K 0.18% 97

Other funds holding LLY

Navalign LLC's LLY Position: Q2 2026 in Review

Navalign LLC increased its Eli Lilly (LLY) stake by 2.4% in Q2 2026, buying an estimated $41.9K and bringing the position to 1,784 shares worth $2.14M. The position accounts for 0.5% of the portfolio, ranked #32.

Navalign LLC first reported a position in LLY in Q1 2021 and has held it in 22 quarters since. 2,000 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Navalign LLC held 1,784 shares of Eli Lilly worth $2.14M as of Q2 2026.
  • Navalign LLC bought 41 Eli Lilly shares in Q2 2026, an estimated $41.9K.
  • Eli Lilly made up 0.5% of Navalign LLC's portfolio in Q2 2026, its #32 holding.
  • Navalign LLC first reported a position in Eli Lilly in Q1 2021 and has held it in 22 quarters since.
  • 2,000 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Navalign LLC's 13F filing for Q2 2026, filed 28 Jul 2026.